We found that chronic treatment with high-dose atorvastatin significantly reduced the levels of TLR4, TRAF6, and NF-κB, inhibited the activation of microglia and astrocytes, alleviated hippocampal pathologic alterations and neuronal apoptosis, and improved spatial learning ability and memory impairment in AD rats. This evidence concerns the gene TLR4 and Alzheimer disease.